Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2023-05-18 00:00:00 ET · period of report 2023-05-16 · accession 0001437749-23-015170 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-18 | 2023-05-16 | LMAT | LeMaitre George W | COB, CEO, Dir, 10% | M - OptEx | $40.26 | +24.2K | 2.37M | +1% | +$973.6K |
| DM | 2023-05-18 | 2023-05-17+ | LMAT | LeMaitre George W | COB, CEO, Dir, 10% | S - Sale+OE | $63.36 | -20.1K | 2.37M | -0.8% | -$1.27M |
| DM | 2023-05-18 | 2023-05-16 | LMAT | LeMaitre George W | COB, CEO, Dir, 10% | M - OptEx | $0.00 | -24.2K | 23.2K | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-16 | M | A | 8,610 | $35.48 | 2,357,923 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Common | Common Stock | 2023-05-16 | M | A | 7,837 | $37.29 | 2,365,760 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 3 | Common | Common Stock | 2023-05-16 | M | A | 7,734 | $48.60 | 2,373,494 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 4 | Common | Common Stock | 2023-05-18 | S | D | 250 | $64.02 | 2,353,408 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $63.94 to $64.27 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 5 | Common | Common Stock | 2023-05-17 | S | D | 33 | $64.82 | 2,371,318 | D | — | — | |
| 6 | Common | Common Stock | 2023-05-18 | S | D | 17,660 | $63.26 | 2,353,658 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $62.94 to $63.92 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 7 | Common | Common Stock | 2023-05-17 | S | D | 2,143 | $64.05 | 2,371,351 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $63.77 to $64.47 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-05-16 | M | D | 7,837 | $0.00 | 23,508 | D | $37.29 · 2020-12-02 to 2027-12-02 | 7,837 Common Stock | (F6) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years with the final vesting occurring on the eleventh month after the fourth anniversary. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-05-16 | M | D | 8,610 | $0.00 | 17,220 | D | $35.48 · 2019-12-20 to 2026-12-20 | 8,610 Common Stock | (F5) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. |
| 10 | Derivative | Stock Option (Right to Buy) | 2023-05-16 | M | D | 7,734 | $0.00 | 23,200 | D | $48.60 · 2021-12-11 to 2028-12-11 | 7,734 Common Stock | (F7) This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. |